What we do
Garcia-Doval I, Ingram JR, Naldi L, et al. Case reports in dermatology: loved by clinicians, loathed by editors, and occasionally important. Br J Dermatol. 2016;175:449-51.
Doerken S, Mockenhaupt M, Naldi L, et al. The case-crossover design via penalized regression. BMC Med Res Methodol. 2016 Aug 22;16:103.
Barbarot S, Rogers NK, Abuabara K, et al. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review. J Am Acad Dermatol. 2016 Aug 10.
GBD 2015 HIV Collaborators, Wang H, Wolock TM, Carter A, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016 Aug;3(8):e361-87.
Bencini PL, Tourlaki A, Tretti Clementoni M, et al. Double phase treatment with flashlamp-pumped pulsed-dye laser and long pulsed Nd:YAG laser for resistant port wine stains in adults. Preliminary reports. G Ital Dermatol Venereol. 2016;151:281-6.
Eissing L, Rustenbach SJ, Krensel M, et al. Psoriasis registries worldwide: systematic overview on registry publications. J Eur Acad Dermatol Venereol. 2016 May 2.
Glauser S, Rutz M, Cazzaniga S, Hegyi I,et al. Diagnostic value of immunohistochemistry on formalin-fixed paraffin-embedded skin biopsy specimens for bullous pemphigoid. Br J Dermatol. 2016 Apr 23.
Christoph S, Cazzaniga S, Hunger RE, et al. Ultraviolet radiation protection and skin cancer awareness in recreationalathletes: a survey among participants in a running event. Swiss Med Wkly. 2016 Mar 21.
Stanganelli I, Naldi L, Falcini F, et al. Parental Use and Educational Campaigns on Sunbed Use Among Teenagersand Adolescents. Medicine (Baltimore). 2016 Mar;95(11):e3034.
Kaufmann RA, Oberholzer PA, Cazzaniga S, et al. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients. Eur J Dermatol. 2016 Mar 17.
Strober BE, Bissonnette R, Fiorentino D, et al. Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). J Am Acad Dermatol. Epub 2016 Feb 4.
Cazzaniga S, Ballmer-Weber BK, et al. Medical, psychological and socio-economic implications of chronic hand eczema: a cross-sectional study. J Eur Acad Dermatol Venereol. 2016;30:628-37.
Modalsli EH, Snekvik I, Ĺsvold BO, et al. Validity of Self-Reported Psoriasis in a General Population: The HUNT Study, Norway. J Invest Dermatol. 2016;136:323-5.
Paul C, Bewley A, Girolomoni G, et al. Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis: Interim Results From A Large Prospective, Observational Study. Value Health. 2015 Nov;18(7):A429.Epub 2015 Oct 20.
Johnson RW, Alvarez-Pasquin MJ, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3:109-20.
Megna M, Bettoli V, Chimenti S, et al. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. G Ital Dermatol Venereol. 2015;150:731-9.
Modalsli EH, Snekvik I, Ĺsvold BO, et al. Validity of Self-Reported Psoriasis in a General Population: The HUNT Study, Norway. J Invest Dermatol. 2015 Sep 30. [Epub ahead of print]
Johnson RW, Alvarez-Pasquin MJ, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3:109-20.
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1:505-27.
Papp K, Gottlieb AB, Naldi L, et al. Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Drugs Dermatol. 2015;14:706-14.
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jun 7. [Epub ahead of print]
Hay RJ, Augustin M, Griffiths CE, et al.; Board of the International League of Dermatological Societies and the Grand Challenges Consultation groups. The global challenge for skin health. Br J Dermatol. 2015;172:1469-72
Goff KL, Karimkhani C, Boyers LN, et al. The Global Burden of Psoriatic Skin Disease. Br J Dermatol. 2015 Feb 3. [Epub ahead of print]
Papp K, Gottlieb AB, Naldi L,et al. Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]). J Am Acad Dermatol. 2015 Jan 9. [Epub ahead of print]
Boyers LN, Karimkhani C, Naghavi M, et al. Global mortality from conditions with skin manifestations. J Am Acad Dermatol. 2014 Oct 2. [Epub ahead of print]
Ribero S, Stieger M, Quaglino P, et al. Efficacy of topical tacrolimus for oral lichen planus: real-life experience in a retrospective cohort of patients with a review of the literature. J Eur Acad Dermatol Venereol. 2014 Oct 13. [Epub ahead of print]
Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Jul 21. [Epub ahead of print]
Karimkhani C, Boyers LN, Margolis DJ, et al. Comparing cutaneous research funded by the national institute of arthritis and musculoskeletal and skin diseases with 2010 global burden of disease results. PLoS One. 2014 Jul 8;9(7).
Gyulai R, Bagot M, Griffiths CE, et al. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists. J Eur Acad Dermatol Venereol. 2014 Apr 15. [Epub ahead of print]
Hay RJ, Johns NE, Williams HC, et al. The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions. J Invest Dermatol. 2013 Oct 28. [Epub ahead of print]
Bastuji-Garin S, Sbidian E, Gaudy-Marqueste C et al. Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis. PLoS One. 2013 Aug 26;8(8):e64733.
Gelardi M, Iannuzzi L, Greco Miani A, et al. Double-blind placebo-controlled randomized clinical trial on the efficacy of Aerosal(®) in the treatment of sub-obstructive adenotonsillar hypertrophy and related diseases. Int J Pediatr Otorhinolaryngol. 2013 Aug 22. [Epub ahead of print]
Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. The RegiSCAR study group. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013 Jul 16. [Epub ahead of print].
Gottlieb AB, L Naldi, Chevrier M, et al. Major adverse cardiovascular events in the psoriasis longitudinal assessment and registry (PSOLAR) study: Current status of observations. J Am Acad Dermatol. 2013;68:205.
Neale RE, Weissenborn S, Abeni D, et al. Human Papilloma Virus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013 Feb 8.
Sekula P, Dunant A, Mockenhaupt M, et al. Comprehensive Survival Analysis of a Cohort of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. J Invest Dermatol. 2013 Feb 7.
Cortés B, Khelifa E, Clivaz L, et al. Mortality Rate in Bullous Pemphigoid: A Retrospective Monocentric Cohort Study. Dermatology. 2012 Dec 21. [Epub ahead of print]
Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2197-223.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2163-96.
Salomon JA, Vos T, Hogan DR et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2013;380:2129-43.
Antonsson A, Waterboer T, Bouwes et al. The EPI-HPV-UV-CA group. Longitudinal study of seroprevalence and serostability of 34 human papillomavirus types in European organ transplant recipients. Virology. 2012 Nov 19. [Epub ahead of print]
Antonsson A, Pawlita M, Feltkamp MC, et al. Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients. J Med Virol. 2012 Nov 21. [Epub ahead of print]
Augustin M, Alvaro-Gracia JM, et al. A framework for improving the quality of care for people with psoriasis. J Eur Acad Dermatol Venereol. 2012;26 Suppl 4:1-16.
Naldi L, Cazzaniga S, Borradori L. Bullous pemphigoid: simple measures for a complex disease. J Invest Dermatol. 2012 Aug;132(8).
Ormerod AD, Augustin M, Baker C,et al. Challenges for synthesising data in a network of registries for systemic psoriasis therapies. Dermatology. 2012;224:236-43.
Della Torre R, Combescure C, Cortes B, et al. Clinical presentations and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort. Br J Dermatol. 2012 Jun 18. [Epub ahead of print].
Lee HY, Dunant A, Sekula P, et al. The role of prior corticosteroids on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: A case-control analysis of patients selected from the multi-national EuroSCAR and RegiSCAR studies. Br J Dermatol. 2012 May 28. [Epub ahead of print]
Nacoti M, Cazzaniga S, Lorusso F, et al. The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation. Pediatr Transplant. 2012 Mar 19.
Tang YH, Mockenhaupt M, Henry A, et al. Poor relevance of a lymphocyte proliferation assay in lamotrigine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis. Clin Exp Allergy. 2011 Oct 6.
Gomez-Lira M, Tessari G, Mazzola S, et al. Analysis of the 3'UTR of the prostaglandin synthetase-2 (PTGS-2/COX-2) gene in non-melanoma skin cancer after organ transplantation. Exp Dermatol. 2011 Sep 6. [Epub ahead of print]
Sampogna F, Bouwes Bavinck JN, et al. Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients. J Gen Virol. 2011 Sep 7. [Epub ahead of print]
Naldi L, Saunes M. Methotrexate, a drug for the years to come. Br J Dermatol. 2011;165:230-1.
Weissenborn S, Neale RE, Waterboer T, et al.; EPI-HPV-UV-CA group. Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol. 2011 Jul 27. [Epub ahead of print]
Genin E, Schumacher M, Roujeau JC, et al. Genome-Wide Association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe. Orphanet J Rare Dis. 2011;6):52.
Proby CM, Harwood CA, Neale RE,et al.; the EPI-HPV-UV-CA group. A Case-Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. Am J Transplant. 2011;11:1498-1508.
Cortés B, Marazza G, Naldi L, et al. Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol. 2011 May 17.
Sekula P, Liss Y, Davidovici B, et al. Evaluation of SCORTEN on a Cohort of Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Included in the RegiSCAR Study. J Burn Care Res. 2011 Jan 11. [Epub ahead of print]
Bavinck JN, Neale RE, Abeni D, et al.; on behalf of the EPI-HPV-UV-CA group. Multicenter Study of the Association between Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma. Cancer Res. 2010 Nov 23. [Epub ahead of print]
Mallitt KA, O'Rourke P, Bouwes Bavinck JN,et al.; EPI-HPV-UV-CA Group. An analysis of clustering of betapapillomavirus antibodies. J Gen Virol. 2010;91(Pt 8):2062-7.
Langan S, Schmitt J, Coenraads PJ, et al. European Dermato-Epidemiology Network (EDEN). The reporting of observational research studies in dermatology journals: a literature-based study. Arch Dermatol. 2010;146:534-41.
García-Doval I, Naldi L. Introduction to Clinical Research in Dermatology: The Link Between Clinical Practice and Research. Actas Dermosifiliogr. 2009;100:749-755.
Nijsten T, Spuls PI, Naldi L, et al. The misperception that clinical trial data reflect long-term drug safety: lessons learned from Efalizumab's withdrawal. Arch Dermatol. 2009;145:1037-9.
Weissenborn SJ, Neale R, de Koning MN,et al.; EPI-HPV-UV-CA Group. Prevalence and multiplicity of cutaneous beta papilloma viruses in plucked hairs depend on cellular DNA input. J Virol Methods. 2009;161:280-3.
Waterboer T, Neale R, Michael KM, et al. EPI-HPV-UV-CA Group. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol. 2009;90(Pt 8):1986-98.
Marazza G, Pham HC, Schärer L,et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009 May 8. [Epub ahead of print]
de Koning MN, Weissenborn SJ, Abeni D, et al. Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol. 2009 Mar 25. [Epub ahead of print]
Naldi L. The search for effective and safe disease control in psoriasis. Lancet. 2008;371(9621):1311-2.
Naldi L. Health-related quality of life:from health economics to bedside? Dermatology. 2007;215:273-6.
Ingordo V, Gentile C, Iannazzone SS, et al. The 'EpiEnlist' project: a dermo-epidemiologic study on a representative sample of young Italian males. Prevalence of selected pigmentary lesions. J Eur Acad Dermatol Venereol. 2007;21:1091-6.
Farina C, Gotti E, Parma A, et al. Pheohyphomycotic soft tissue disease caused by Alternaria alternata in a kidney transplant patient: a case report and literature review. Transplant Proc. 2007;39(5):1655-9.
Lira MG, Mazzola S, Tessari G, et al. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation. Br J Dermatol. 2007;157:49-57.
Bouwes Bavinck JN, Euvrard S, et al; EPI-HPV-UV-CA group. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol. 2007;127:1647-56.
Tartaglia S, Belloni-Fortina A, Stefano P, et al. The +61 A-G polymorphism of the epidermal growth factor gene is not associated with occurrence of non-melanocytic skin tumors in transplant recipients. J Dermatol Sci. 2007;46:147-9
Williams HC, Naldi L, Paul C, et al. Conflicts of interest in dermatology. Acta Derm Venereol. 2006;86:485-97.
Tessari G, Naldi L, Boschiero L, et al. Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients:a multicenter study. Eur J Dermatol. 2006;16:553-7.
Lira MG, Provezza L, Malerba G, et al. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol. 2006;15:958-65.
Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2006 Jun;(15):2249-83.
Naldi L, Chatenoud L. [Psoriasis and cancer: more than a chance link] Ann Dermatol Venereol. 2006;133:221-3.
Jobling R, Naldi L. Assessing the impact of psoriasis and the relevance of qualitative research. J Invest Dermatol. 2006;126:1438-40.
Naldi L, Manfrini R, Martin L, et al. Feasibility of a web-based continuing medical education program in dermatology: the DermoFAD experience in Italy. Dermatology. 2006;213:6-11.
Langan SM, Bouwes Bavinck JN, Coenraads PJ, et al; European Dermato-Epidemiology Network. Update on the activities of the European Dermato-Epidemiology Network (EDEN). Dermatology. 2006;213:1-2.
Williams H, Svensson A, Diepgen T, et al; European Dermato-Epidemiology Network (EDEN). Epidemiology of skin diseases in Europe. Eur J Dermatol. 2006;16:212-8.
Naldi L, Chatenoud L. Psoriasis. N Engl J Med. 2005;353:848-50.
La Vecchia C, Gallus S, Naldi L. Tobacco and skin disease. Dermatology. 2005;211:81-3.
Naldi L, Griffiths CE. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol. 2005;152:597-615.
Tessari G, Forni A, Naldi L, et al. Malignant melanoma in a candidate for heart transplantation. Dermatology. 2005;210:233-6.
Naldi L. A new era in the management of psoriasis? Promises and facts. Dermatology. 2005;210:179-81.
Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2004;(11):2140-67.
Ingordo V, Naldi L, Fracchiolla S, et al. Prevalence and risk factors for superficial fungal infections among Italian Navy Cadets. Dermatology. 2004;209:190-6.
Van Coevorden AM, Coenraads PJ, Svensson A, et al. European Dermato-Epidemiology Network (Eden). Overview of studies of treatments for hand eczema-the EDEN hand eczema survey. Br J Dermatol. 2004;151:446-51.
Bosetti C, La Vecchia C, Naldi L, et al. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res. 2004;14:301-9.
Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:121-8.
Ingordo V, Naldi L, Colecchia B, et al. Prevalence of pityriasis versicolor in young Italian sailors. Br J Dermatol. 2003;149:1270-2.
Ingordo V, D'Andria G, Gentile C, et al. X-linked ichthyosis in southern Italy. J Am Acad Dermatol. 2003;49:962-3.
Ingordo V, D'Andria G, Gentile C, et al. Frequency of X-linked ichthyosis in coastal southern Italy: a study on a representative sample of a young male population. Dermatology. 2003;207:148-50.
Naldi L. Counting genetic skin disease in the population. Dermatology. 2003;207:125-6.
Naldi L, Svensson A, Diepgen T, et al. European Dermato-Epidemiology Network. Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol. 2003;120:738-41.
Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2002;(8):1688-708.
Braun RP, Rabinovitz HS, Krischer J, et al. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol. 2002;138:1556-60.
Naldi L, Saurat JH. Dermatology launches the 'Evidence-Based Case Report' section. Dermatology. 2002; 205:224-5.
Naldi L, Rzany B. Chronic plaque psoriasis. Clin Evid. 2002; 7:1488-507.
Naldi L. Alefacept for psoriasis: promising drug, open questions. Arch Dermatol. 2002;138:1238-40.
Campanelli A, Naldi L. A retrospective study of the effect of long-term topical application of retinaldehyde (0.05%) on the development of actinic keratosis. Dermatology. 2002;205:146-52.
Naldi L. The epidemiology of fragrance allergy: questions and needs. Dermatology. 2002;205:89-97.
Naldi L, Braun R, Saurat JH. Evidence-based dermatology: a need to reset the agenda. Dermatology. 2002;204:1-3.
Naldi L. Turner's syndrome, melanocytic nevi and melanoma. Dermatology. 2001;203:275.
Naldi L. Does clinical research help pemphigus patients? Precautions and suggestions. Dermatology. 2001;203:199-200.
Naldi L, Minelli C. Exploring the causes of cutaneous B-cell lymphoma: we should learn from the Lyme disease experience. Dermatology. 2000;201:353-5.
Ingordo V, Fracchiolla S, Figliola F, et al. Prevalence and awareness of tinea pedis in Italian sailors. Dermatology. 2000;201:349-50.
Naldi L, Lovati S, Farina C, et al. Paecilomyces marquandii cellulitis in a kidney transplant patient. Br J Dermatol. 2000;143:647-9.
Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol. 1999;48:839-46.
Williams HC, Po AL, Murrel D, et al. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol. 1998;139:757-8.
Carli P, De Giorgi V, Naldi L, et al. Reliability and inter-observer agreement of dermoscopic diagnosis of melanoma and melanocytic naevi. Dermoscopy Panel. Eur J Cancer Prev. 1998;7:397-402.
Williams H, Adetugbo K, Po AL, et al. The Cochrane Skin Group. Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology. Arch Dermatol. 1998;134:1620-6.
Naldi L. Cigarette smoking and psoriasis. Clin Dermatol. 1998;16:571-4.
Rzany B, Naldi L, Schafer T, et al. The diagnosis of psoriasis: diagnostic criteria. Br J Dermatol. 1998;138:917.
Morison WL, Baughman RD, Day RM, et al. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol. 1998;134:595-8.
Nobili A, Gebru F, Rossetti A, et al. Doctorline: a private toll-free telephone medical information service. Five years of activity: old problems and new perspectives. Ann Pharmacother.1998;32:120-5.
Di Landro A, Marchesi L, Naldi L, et al. A case of hypopigmented mycosis fungoides in a young Caucasian boy. Pediatr Dermatol. 1997;14:449-52.
Conforti A, Gugliemo L, Naldi L, et al. Brodimoprim: adverse drug reactions from spontaneous reporting. Br J Clin Pharmacol. 1997;44:411.
Naldi L. Psoriasis: latest advances in understanding and novel therapeutic approaches. Expert Opin Investig Drugs. 1997;6:895-8.
Naldi L, Colombi A. News from dermatology. Riv Inferm. 1997;16:41-7.
Di Landro A, Naldi L, Locati F, et al. Nodular lesions on fingertips. Diagnosis: cutaneous sarcoidosis. Arch Dermatol. 1996;132:460, 463.
Naldi L, Adamoli L, Fraschini D, et al. Number and distribution of melanocytic nevi in individuals with a history of childhood leukemia. Cancer. 1996;77:1402-8.
Parazzini F, D'Oro LC, Naldi L, et al. Sexually transmitted diseases and risk of HIV infection. Acta Derm Venereol. 1996;76:147-9.
Parazzini F, Cavalieri D'oro L, Naldi L, et al. Number of sexual partners, condom use and risk of human immunodeficiency virus infection. Int J Epidemiol. 1995;24:1197-203.
Naldi L. Psoriasis. Dermatol Clin. 1995;13:635-47.
Naldi L, Locati F, Finazzi G, et al. Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer. 1995;75:2784-5.
d'Oro LC, Parazzini F, Naldi L, et al. Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review. Genitourin Med. 1994;70:410-7.
Marchesi L, Naldi L, Locati F, et al. Combined Clark's nevus. Am J Dermatopathol. 1994;16:364-71.
Naldi L, Tognoni G, Cainelli T. Analytic epidemiology in psoriasis. J Invest Dermatol. 1994;102:19S-23S.
Brevi A, Naldi L, Cainelli T, et al. Prevalence and awareness of hepatitis B virus carrier status in Italy. Genitourin Med. 1993;69:241.
Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies inpatients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis. 1993;52:219-22.
Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92-6.
Naldi L, Brevi A, Cavalieri d'Oro L, et al. Painful distal erythema and thrombocytosis. Erythromelalgia secondary to thrombocytosis. Arch Dermatol. 1993;129:105-6,109.
Parazzini F, d'Oro LC, Bianchi C, et al. Determinants of hepatitis B virus surface antigen positivity in adults attending sexually transmitted disease clinics in Italy. Genitourin Med. 1992;68:345-6.
Naldi L, Bronzoni M, d'Oro LC, et al. Figurate erythema, photosensitivity, and conjunctival irritation of recent onset.Subacute cutaneous lupus erythematosus (SCLE) and keratoconjunctivitis sicca. Arch Dermatol. 1992;128:1265,1268.
Naldi L, Parazzini F, Brevi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 1992;127:212-7.
Naldi L, Carrel CF, Parazzini F, et al. Development of anthralin short-contact therapy in psoriasis: survey of published clinical trials. Int J Dermatol. 1992;31:126-30.
Naldi L, Finazzi G, Brevi A, et al. Antiphospholipid antibodies and melanoma: a link. Dermatology. 1992;184:156.
Naldi L, Marchesi L, Locati F, et al. Multiple papular and nodular lesions in a tall woman. Nevoid basal cell carcinoma syndrome. Arch Dermatol. 1991;127:1717-8,1720-1.
Parazzini F, Naldi L, Sena P, et al. Risk factors for HIV infection in adults attending sexually transmitted disease clinics in Italy. Int J Epidemiol. 1991;20:758-63.
Naldi L, Rozzoni M, Finazzi G, et al. Etretinate therapy and thrombocytopenia. Br J Dermatol. 1991;124:395.
Naldi L, Zucchi A, Brevi A, et al. Corticosteroids and post-herpetic neuralgia. Lancet. 1990;336:947
Naldi L, Locati F, Marchesi L, et al. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol. 1990;126:1103-4.
Naldi L, Parazzini F, Cainelli T. Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group. J Am Acad Dermatol. 1990;22:654-6.
Naldi L, Marchesi L, Finazzi G, et al. Antiphospholipid antibodies and necrotizing purpura. Dermatologica. 1990;180:272-5.
Naldi L, Parazzini F, Sena P, et al. Frequency of HIV infection in patients attending sexually transmitted disease clinics in Italy. Int J Epidemiol. 1989;18:999-1000.